The global gene synthesis market was valued at USD 2.7 billion in 2025 and is projected to grow from USD 3.1 billion in 2026 to USD 9.3 billion by 2033, registering a compound annual growth rate (CAGR) of 16.7% from 2026 to 2033. North America dominated the market in 2025, accounting for 37.5% of global revenue. Market growth is driven by increasing investments in synthetic biology, supportive government policies, advancements in DNA synthesis technologies, and rising demand for personalized medicine and gene-based therapies.

Gene synthesis involves the artificial production of DNA sequences for use in biomedical research, drug discovery, vaccine development, genetic engineering, and synthetic biology. Growing applications in cell and gene therapy, biopharmaceutical manufacturing, and precision medicine are creating new opportunities for market participants. In addition, continued investment in genomics research and the development of advanced therapeutic technologies are expected to support market expansion through 2033.

Gene Synthesis Market Size and Forecast

Key Gene Synthesis Market Trends and Insights

• By method: Solid-phase synthesis accounted for the largest revenue share of 35.1% in 2025, supported by its role in the production of custom DNA sequences for research and biotechnology applications.
• By service: Antibody DNA synthesis held the largest revenue share of 60.9% in 2025, reflecting demand for antibody-related research and therapeutic development.
• By application: Gene and cell therapy development represented the largest application segment, accounting for 35.2% of market revenue in 2025.
• By end use: Academic and government research institutes dominated the market with a 54.4% share in 2025, supported by ongoing investments in genomics, molecular biology, and synthetic biology research.
• By region: North America captured 37.5% of global revenue in 2025, making it the leading regional market.
• By country: The U.S. accounted for the largest share of the North American gene synthesis market in 2025.

Go Deeper! Ask Prism AI

about the Global construction equipment market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.

Gene Synthesis Market Growth Drivers

1. Rising Demand for Personalized Medicine and Precision Therapeutics

The growing adoption of personalized medicine and precision therapeutics is a major driver of the gene synthesis market. Personalized medicine uses genetic and molecular information to develop treatments, diagnostic approaches, and therapeutic strategies tailored to individual patients. Gene synthesis enables researchers to design and produce specific DNA sequences required for biomarker identification, companion diagnostics, target validation, and the development of advanced biologics.

The increasing prevalence of cancer, rare genetic disorders, and chronic diseases is accelerating the use of genomics-based approaches in drug discovery and clinical research. As pharmaceutical and biotechnology companies increasingly focus on targeted treatments, demand for synthetic genes is expected to rise across therapeutic development and translational research.

According to a Wellcome article published in January 2025, large-scale genomic research and sequencing initiatives are contributing to improvements in disease prediction, cancer treatment, and personalized healthcare. These developments are expected to support the use of gene synthesis technologies in biomarker discovery, therapeutic research, and the validation of disease-related targets.

Download a free sample report or claim your copy of this full market intelligence report

Gene Synthesis Market Restraints and Challenges

Shortage of Skilled Professionals

The shortage of trained professionals in gene synthesis, molecular biology, biotechnology, and related disciplines remains a challenge for market participants. Gene synthesis operations require specialized expertise in DNA design, laboratory procedures, quality control, and the management of advanced synthesis technologies.

Insufficient access to experienced personnel can affect operational efficiency, research timelines, service quality, and the ability of companies to scale production. To address this challenge, market participants are collaborating with universities and research institutions to provide online workshops, on-site training, sponsored research projects, and practical education programs.

These initiatives can help strengthen the biotechnology talent pipeline and improve the availability of skilled professionals. However, workforce development remains an important consideration as demand for specialized gene synthesis services increases.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Gene Synthesis Market Dynamics

The gene synthesis market is experiencing strong growth as synthetic genes become increasingly important in drug discovery, vaccine development, synthetic biology, genetic engineering, and biopharmaceutical production. Rising investment in genomics, expanding applications in personalized medicine, and increased research activity in cell and gene therapies are supporting market demand.

Technological advancements in DNA synthesis are also contributing to market development by improving sequence design, synthesis capabilities, and the accessibility of custom genetic materials. As synthesis technologies evolve and production processes become more efficient, gene synthesis services are expected to support a wider range of research and commercial applications.

At the same time, market participants must address challenges associated with workforce availability, technical complexity, and the need for reliable synthesis and quality-control processes.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Gene Synthesis Market: Key Companies

The following companies are identified as key participants in the global gene synthesis market:

• GenScript

• Azenta Life Sciences (GENEWIZ)

• Boster Biological Technology

• Twist Bioscience

• ProteoGenix, Inc.

• Biomatik

• ProMab Biotechnologies, Inc.

• Thermo Fisher Scientific, Inc.

Explore our dedicated business services:

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today